Stock Analysis

High Insider Ownership Growth Stocks To Consider In January 2025

SHSE:688253
Source: Shutterstock

As global markets navigate a mixed start to 2025, with U.S. stocks finishing the previous year on a high note despite recent economic concerns, investors are keenly observing companies with strong insider ownership as potential opportunities for growth. In this context, firms where insiders hold significant stakes can be particularly appealing, as their vested interest in the company's success often aligns with shareholder value creation and resilience amid fluctuating market conditions.

Top 10 Growth Companies With High Insider Ownership

NameInsider OwnershipEarnings Growth
SKS Technologies Group (ASX:SKS)29.7%24.8%
Propel Holdings (TSX:PRL)23.8%37.6%
CD Projekt (WSE:CDR)29.7%27%
Medley (TSE:4480)34%31.7%
Pharma Mar (BME:PHM)11.8%56.2%
Plenti Group (ASX:PLT)12.8%120.1%
EHang Holdings (NasdaqGM:EH)31.4%79.6%
Brightstar Resources (ASX:BTR)16.2%84.5%
Elliptic Laboratories (OB:ELABS)26.8%111.4%
Findi (ASX:FND)34.8%112.9%

Click here to see the full list of 1498 stocks from our Fast Growing Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

Técnicas Reunidas (BME:TRE)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Técnicas Reunidas, S.A. is an engineering and construction company that specializes in designing and managing industrial plant projects globally, with a market cap of approximately €1.01 billion.

Operations: The company's revenue is primarily derived from the Natural Gas segment at €2.55 billion, followed by Refining at €669.71 million, Petrochemical at €655.17 million, and Low Carbon Technologies contributing €111.52 million.

Insider Ownership: 11.5%

Earnings Growth Forecast: 20.7% p.a.

Técnicas Reunidas shows promising growth potential with earnings expected to grow significantly at 20.7% annually, outpacing the Spanish market. Despite a volatile share price, the company has seen a 55.9% increase in earnings over the past year and is trading below its estimated fair value. Recent results indicate stable sales performance, with net income rising to €65.7 million for the nine months ending September 2024, despite slightly lower revenues compared to last year.

BME:TRE Earnings and Revenue Growth as at Jan 2025
BME:TRE Earnings and Revenue Growth as at Jan 2025

Innovita Biological Technology (SHSE:688253)

Simply Wall St Growth Rating: ★★★★★★

Overview: Innovita Biological Technology Co., Ltd. focuses on the R&D, manufacturing, marketing, and sales of POCT rapid diagnostic products and has a market cap of CN¥4.90 billion.

Operations: The company's revenue is primarily derived from its Diagnostic Kits and Equipment segment, amounting to CN¥720.40 million.

Insider Ownership: 37.1%

Earnings Growth Forecast: 32.4% p.a.

Innovita Biological Technology exhibits strong growth potential, with earnings expected to grow significantly at 32.4% annually, surpassing the Chinese market average. The company reported substantial financial improvements for the nine months ending September 2024, with sales reaching CNY 520.82 million and net income climbing to CNY 244.61 million. Innovita is trading well below its estimated fair value and has completed a share buyback program worth CNY 50.01 million, enhancing shareholder value without recent insider trading activity.

SHSE:688253 Ownership Breakdown as at Jan 2025
SHSE:688253 Ownership Breakdown as at Jan 2025

Rakuten Group (TSE:4755)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Rakuten Group, Inc

Operations: The company generates revenue from its key segments, including Internet Services at ¥1.25 billion, Fin Tech at ¥795.96 million, and Mobile at ¥400.26 million.

Insider Ownership: 27.8%

Earnings Growth Forecast: 72.1% p.a.

Rakuten Group is set for substantial growth, with earnings projected to rise 72.1% annually and revenue expected to increase by 6.8% per year, outpacing the Japanese market. The company trades significantly below its estimated fair value, indicating potential undervaluation. Recent strategic moves include a $550 million fixed-income offering and leadership changes with Masayuki Hosaka's upcoming retirement as Vice Chairman, potentially impacting future governance dynamics positively or negatively depending on execution.

TSE:4755 Earnings and Revenue Growth as at Jan 2025
TSE:4755 Earnings and Revenue Growth as at Jan 2025

Seize The Opportunity

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com